Home »

AtheroNova Inc. Presenting at 15th Annual Rodman & Renshaw Investment Conference

IRVINE, CA — (Marketwired) — 09/04/13 — AtheroNova Inc. (OTCQB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. AtheroNova will be presenting on Monday, September 9 at 12:05pm EDT. The conference is being held Se

AtheroNova CEO Tom Gardner to Present at Rodman & Renshaw Conference Tuesday, September 13

Highlights of Mr. Gardner-s Presentation to Include Recently Announced Maxwell Biotech Group Agreement and MOA of AtheroNova-s AHRO-001 Lead Atherosclerotic Plaque Regression Compound

AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug

Maxwell to Fund Clinical Trials, Become Equity Investor in AtheroNova, and License AHRO-001 for Russia


© 2021 88Finance. All Rights Reserved. Log in

- Copyright by LayerMedia

Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de